Dental Soft-tissue Regeneration Market Size, Share and Growth Outlook, 2026

Dental Soft-tissue Regeneration Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Dental Soft-tissue Regeneration Market size is forecast to increase from $439.04 Million in 2026 to $743.15 Million in 2034 at a CAGR of 6.8% between 2026 and 2034.

The Dental Soft-tissue Regeneration market report provides detailed analysis and outlook of Dental Soft-tissue Regeneration segments including By Material Type (Allografts, Xenografts, Autografts, Synthetic Biomaterials ), By Application (Periodontal Treatment & Root Coverage, Gingival Recession & Gum Repair, Dental Implant Site Development, Maxillofacial Reconstruction), By Patient Demographics (Geriatric Patients, Adult Patients, Pediatric Patients), By End-User Facility (Private Dental Clinics and Periodontal Practices, General and Specialty Hospitals, Academic & Dental Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Dental Soft-Tissue Regeneration Industry Overview

The dental soft-tissue regeneration industry is emerging as a critical segment within regenerative dentistry, periodontal therapy, oral surgery, implant dentistry, and tissue engineering. Dental soft-tissue regeneration technologies are increasingly being utilized to restore gingival tissues, augment alveolar ridges, improve peri-implant soft-tissue architecture, and enhance wound healing following surgical procedures. Growing demand for minimally invasive regenerative treatments, biologically active biomaterials, tissue-engineered scaffolds, and advanced growth-factor therapies is accelerating innovation across the dental soft-tissue regeneration market. Manufacturers, biotechnology companies, and regenerative medicine developers are investing heavily in recombinant proteins, bioengineered collagen matrices, regenerative scaffolds, and three-dimensional bioprinting platforms to improve soft-tissue healing outcomes while reducing dependence on conventional grafting procedures.

Recombinant Growth Factors and Advanced Tissue Regeneration Technologies Driving Innovation

A major trend within the dental soft-tissue regeneration industry is the increasing use of targeted biologic therapies designed to stimulate natural tissue repair mechanisms. Clinical-stage biotechnology company Theradaptive, Inc. continues to advance its RESTORE International Phase I/II Feasibility Study evaluating the OsteoAdapt DE product platform. The study recently completed patient enrollment and is assessing soft-tissue regeneration and alveolar ridge augmentation outcomes relative to traditional xenograft-based treatment approaches. The OsteoAdapt DE technology utilizes proprietary recombinant human bone morphogenetic protein (rhBMP-2) variants engineered specifically for tissue repair and regenerative applications. Unlike conventional grafting materials that primarily provide structural support, these bioactive regenerative therapies are designed to actively stimulate cellular regeneration, tissue integration, and localized healing responses. The growing adoption of recombinant growth factors, regenerative biomaterials, alveolar ridge preservation technologies, and biologically active tissue repair products is expanding the clinical applications of dental soft-tissue regeneration across implantology and periodontal surgery.

Recombinant Human Collagen and 3D Bioprinting Transforming Regenerative Dentistry

The dental soft-tissue regeneration market is also benefiting from advances in recombinant human collagen production and regenerative scaffold manufacturing. CollPlant Biotechnologies recently launched BioFlex, a ready-to-print regenerative platform based on plant-derived recombinant human collagen (rhCollagen). The BioFlex system incorporates Collink.3D 50 and is specifically optimized for High-Resolution Digital Light Processing (DLP) 3D bioprinting applications. This biodegradable polymer matrix enables the fabrication of highly complex soft-tissue scaffolds, tissue-engineered regenerative matrices, surgical tissue models, and advanced pharmaceutical testing structures. The introduction of plant-derived recombinant collagen provides a non-animal-derived alternative for regenerative medicine applications while supporting improved biocompatibility and manufacturing consistency. To facilitate commercial expansion of its rhCollagen and BioInk product portfolio, CollPlant also established a strategic distribution partnership with a major U.S.-based logistics center featuring full current Good Manufacturing Practice (cGMP)-compliant cold-storage infrastructure. Operating as a centralized clinical supply hub for the United States and Canada, the facility is designed to streamline the distribution of regenerative biomaterials and tissue-engineering products. These developments highlight the growing importance of recombinant collagen, regenerative scaffolds, dental tissue engineering, bioprinting technologies, and advanced soft-tissue regeneration solutions within the global dental soft-tissue regeneration industry.

Dental Soft-tissue Regeneration Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Dental Soft-tissue Regeneration market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Geistlich Pharma AG, Institut Straumann AG, ZimVie Inc., Dentsply Sirona Inc., Nobel Biocare Services AG (Envista), BioHorizons IPH, Inc., Botiss Biomaterials GmbH, Tissue Regenix Group plc, Regenity (Collagen Matrix), Septodont Holding. The Dental Soft-tissue Regeneration market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Dental Soft-tissue Regeneration industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Dental Soft-tissue Regeneration Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Dental Soft-tissue Regeneration companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Dental Soft-tissue Regeneration markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Dental Soft-tissue Regeneration Market Competitive Benchmarking and Company Analysis

Leading companies in Dental Soft-tissue Regeneration industry include- Geistlich Pharma AG, Institut Straumann AG, ZimVie Inc., Dentsply Sirona Inc., Nobel Biocare Services AG (Envista), BioHorizons IPH, Inc., Botiss Biomaterials GmbH, Tissue Regenix Group plc, Regenity (Collagen Matrix), Septodont Holding. The Dental Soft-tissue Regeneration market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Dental Soft-tissue Regeneration Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Dental Soft-tissue Regeneration market remains one of the strongest-performing segments in the country.
The US Dental Soft-tissue Regeneration Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Dental Soft-tissue Regeneration market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Dental Soft-tissue Regeneration industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Dental Soft-tissue Regeneration markets

Canada's strong Dental Soft-tissue Regeneration sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Dental Soft-tissue Regeneration market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Dental Soft-tissue Regeneration Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Dental Soft-tissue Regeneration market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Dental Soft-tissue Regeneration population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Dental Soft-tissue Regeneration industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Dental Soft-tissue Regeneration market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Dental Soft-tissue Regeneration sales through 2034

France Dental Soft-tissue Regeneration companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Dental Soft-tissue Regeneration Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Dental Soft-tissue Regeneration distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Dental Soft-tissue Regeneration Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Dental Soft-tissue Regeneration market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Dental Soft-tissue Regeneration industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Dental Soft-tissue Regeneration industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Dental Soft-tissue Regeneration Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Dental Soft-tissue Regeneration market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Dental Soft-tissue Regeneration market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Dental Soft-tissue Regeneration Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Dental Soft-tissue Regeneration Market Segmentation

By Material Type
Allografts
Xenografts
Autografts
Synthetic Biomaterials
By Application
Periodontal Treatment & Root Coverage
Gingival Recession & Gum Repair
Dental Implant Site Development
Maxillofacial Reconstruction
By Patient Demographics
Geriatric Patients
Adult Patients
Pediatric Patients
By End-User Facility
Private Dental Clinics and Periodontal Practices
General and Specialty Hospitals
Academic & Dental Research Institutes

Top Companies in Dental Soft-tissue Regeneration Industry

Geistlich Pharma AG
Institut Straumann AG
ZimVie Inc.
Dentsply Sirona Inc.
Nobel Biocare Services AG (Envista)
BioHorizons IPH, Inc.
Botiss Biomaterials GmbH
Tissue Regenix Group plc
Regenity (Collagen Matrix)
Septodont Holding

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025